Disarm Therapeutics has a total of 181 patents globally, out of which 47 have been granted. Of these 181 patents, more than 87% patents are active. Japan is where Disarm Therapeutics has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Disarm Therapeutics.
Disarm Therapeutics founded in 2016, Disarm Therapeutics is a drug discovery company developing therapies to treat neurological diseases by preventing axonal degeneration. Its treatments target conditions like multiple sclerosis, ALS, glaucoma, and peripheral neuropathies by preserving axonal integrity. Acquired by Eli Lilly, Disarm aims to address acute disorders of the central, ocular, and peripheral nervous systems.
Do read about some of the most popular patents of Disarm Therapeutics which have been covered by us in this article and also you can find Disarm Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Disarm Therapeutics patent portfolio.
How many patents does Disarm Therapeutics have?
Disarm Therapeutics has a total of 181 patents globally. These patents belong to 29 unique patent families. Out of 181 patents, 157 patents are active.
How Many Patents did Disarm Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Disarm Therapeutics Applications Filed | Disarm Therapeutics Patents Granted |
| 2025 | – | 13 |
| 2024 | 15 | 26 |
| 2023 | 10 | 5 |
| 2022 | 15 | 3 |
| 2021 | 67 | – |
| 2020 | 32 | – |
| 2019 | 36 | – |
| 2017 | 6 | – |
How many Disarm Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Disarm Therapeutics File in Different Countries?
Countries in which Disarm Therapeutics Filed Patents
| Country | Patents |
| Japan | 19 |
| United States of America | 18 |
| Europe (EPO) | 15 |
| Canada | 15 |
| China | 15 |
| Taiwan | 6 |
| Pakistan | 5 |
| Australia | 5 |
| Argentina | 5 |
| India | 4 |
| Korea (South) | 3 |
| Hong Kong (S.A.R.) | 3 |
| South Africa | 3 |
| Brazil | 3 |
| Israel | 3 |
| Mexico | 3 |
| Spain | 2 |
| Germany | 2 |
| Malaysia | 2 |
| Philippines | 2 |
| Italy | 2 |
| Dominican Republic | 2 |
| Ecuador | 2 |
| Chile | 2 |
| Viet Nam | 2 |
| Costa Rica | 2 |
| Singapore | 2 |
| Indonesia | 2 |
| Peru | 2 |
| Eurasia | 2 |
| Saudi Arabia | 2 |
| Africa | 2 |
| Colombia | 2 |
| New Zealand | 2 |
| Ukraine | 1 |
| Panama | 1 |
| Jordan | 1 |
Where are Research Centres of Disarm Therapeutics Patents Located?
10 Best Disarm Therapeutics Patents
WO2018057989A1 is the most popular patent in the Disarm Therapeutics portfolio. It has received 63 citations so far from companies like Checkmate Therapeutics and Sironax Ltd.
Below is the list of 10 most cited patents of Disarm Therapeutics:
| Publication Number | Citation Count |
| WO2018057989A1 | 63 |
| WO2019236890A1 | 26 |
| WO2021142006A1 | 14 |
| WO2020081923A1 | 14 |
| WO2019236879A1 | 14 |
| WO2019236884A1 | 11 |
| WO2022046606A1 | 10 |
| WO2021207308A1 | 5 |
| WO2021207302A1 | 5 |
| WO2021108602A1 | 5 |
What Percentage of Disarm Therapeutics US Patent Applications were Granted?
Disarm Therapeutics (Excluding its subsidiaries) has filed 18 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Disarm Therapeutics patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Disarm Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Eli Lilly (Inhouse IP Dept.) | 17 | 100.00% |
| Nielsen IP Law Llc | 1 | 0% |
What are Disarm Therapeutics key innovation segments?
What Technologies are Covered by Disarm Therapeutics?
The chart below distributes patents filed by Disarm Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Disarm Therapeutics thinks it’s important to protect particular technological inventions.
R&D Focus: How has Disarm Therapeutics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Disarm Therapeutics?
